本文源自：市场资讯 作者：公告君 罗牛山公告称，2026年1月销售生猪5.91万头，环比增长0.93%，同比增长50.72%；销售收入10316.03万 元，环比增长3.55%，同比增长25.03%。上述数据未经审计，仅作为阶段性数据供投资者参考。本月生 猪销售数量增加主要因临近春节客户需求增长、商品猪出栏增加所致。披露仅包含生猪养殖业务销售情 况不含其他业务，生猪市场价格大幅波动可能对公司经营业绩产生重大影响，敬请投资者审慎决策注意 风险。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 ...

正邦科技方面表示，公司1月份生猪销售数量同比增幅较大主要是公司业务逐步恢复所致。 同一天，湘佳股份亦公告称，公司1月份销售活禽403.27万只，销售收入9034.98万元，同比分别增长 1.15%、10.42%。(完)【编辑:付子豪】 针对业绩变动的原因，罗牛山方面表示，1月生猪销售数量增加的主要原因是临近春节客户需求有所增 长，商品猪出栏增加所致。 正邦科技发布了1月份生猪销售情况简报称，公司2026年1月销售生猪92.75万头(其中，仔猪53.05万头， 商品猪39.7万头)，同比上升62.33%；销售收入8.16亿元，同比上升19.69%。 中新社北京2月9日电 (记者 陈康亮)三家中国A股养殖公司9日发布1月销售简报。数据显示，公布简报的 三家公司销售收入同比均实现正增长，最多同比增逾25%。 其中，罗牛山9日发布2026年1月畜牧行业销售简报称，公司2026年1月销售生猪5.91万头，环比增长 0.93%，同比增长50.72%；销售收入约1.03亿元(人民币，下同)，环比增长3.55%，同比增长25.03%。 ...

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

智通财经APP讯，罗牛山(000735.SZ)发布公告，公司2026年1月销售生猪5.91万头，环比增长0.93%，同 比增长50.72%；销售收入1.03亿元，环比增长3.55%，同比增长25.03%。本月生猪销售数量增加的主要 原因是临近春节客户需求有所增长，商品猪出栏增加所致。 ...

证券代码：000735 证券简称：罗牛山 公告编号：2026-005 罗牛山股份有限公司 2026 年 1 月畜牧行业销售简报 本月生猪销售数量增加的主要原因是临近春节客户需求有所增长，商 品猪出栏增加所致。 三、风险提示 （一）上述披露仅包含公司生猪养殖业务销售情况，不含其它业务。 （二）生猪市场价格的大幅波动（下降或上升），都可能会对公司的 经营业绩产生重大影响，敬请广大投资者审慎决策，注意投资风险。 （三）生猪市场价格变动的风险是整个生猪生产行业的系统风险，对 任何一家生猪生产者来说，都是客观存在的、不可控制的外部风险。 四、其他提示 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、2026 年 1 月份生猪销售情况 公司 2026 年 1 月销售生猪 5.91 万头，环比增长 0.93%,同比增长 50.72%；销售收入 10,316.03 万元，环比增长 3.55%，同比增长 25.03%。 上述数据未经审计，与定期报告披露的数据可能存在差异，因此上述 数据仅作为阶段性数据供投资者参考。 二、原因说明 《证券时报》、《中国证券报》以及巨潮资讯网（ ...

罗牛山公告称，2026年1月销售生猪5.91万头，环比增长0.93%，同比增长50.72%；销售收入10316.03万 元，环比增长3.55%，同比增长25.03%。生猪销售数量增加主要因临近春节客户需求增长、商品猪出栏 增加。此外，公告提示披露仅含生猪养殖业务，生猪价格波动或影响业绩，提醒投资者注意风险。 ...

Group 1 - Intercontinental Oil and Gas focuses on oil exploration and development, with significant operations in Kazakhstan and the Malacca Strait, benefiting from the Hainan Free Trade Port's zero-tariff policy which will reduce equipment import costs and enhance cross-border energy trade efficiency, with a projected 30% increase in trade scale over the next three years [1][34] - Jinpan Technology, a leading manufacturer of high-end power distribution equipment, will benefit from reduced raw material costs and a 15% corporate income tax reduction, enhancing profitability and enabling expansion into the ASEAN power equipment market [2][35] - Hainan Airlines, a major player in the aviation sector, expects a significant increase in passenger traffic due to the visa-free policy for 86 countries and duty-free upgrades, with projected passenger volume exceeding 80 million by 2026 [3][36] Group 2 - Junda Co., a top photovoltaic cell manufacturer, anticipates growth in its solar business due to reduced equipment costs and tax incentives, with plans to participate in Hainan's integrated wind and solar storage projects [4][37] - Caesar Travel, a comprehensive tourism service provider, expects a doubling of cross-border tourism business and a significant increase in tourist arrivals, with projections of 180 million visitors by 2026 [5][38] - Xinda A, a diversified company focusing on motorcycle manufacturing and coal mining, aims to leverage the zero-tariff policy to enhance profitability and expand into the electric vehicle market [6][39] Group 3 - ST Huluwawa, a leading pediatric pharmaceutical company, will benefit from reduced raw material costs and tax incentives, with plans to expand into the ASEAN pharmaceutical market [8][40] - Hainan Ruize, a construction industry leader, anticipates a surge in infrastructure demand with projected investments exceeding 100 billion by 2026, benefiting from the Hainan Free Trade Port's policies [9][42] - Hainan Airport, a key player in airport operations, expects a doubling of cargo business and significant passenger growth due to the visa-free policy and duty-free upgrades [10][43] Group 4 - Hainan Development, an investment platform, anticipates a substantial increase in duty-free sales, projected to exceed 100 billion by 2026, benefiting from the Hainan Free Trade Port's policies [11][45] - Hainan Highway, a major highway operator, expects a significant increase in traffic volume, projected to exceed 200 million vehicles by 2026, benefiting from the integration of tourism and real estate [20][56] - Hainan Rubber, the world's largest natural rubber producer, aims to expand its market presence in ASEAN due to favorable trade policies and tax incentives [21][57]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000735 证券简称：罗牛山 公告编号：2026-004 罗牛山股份有限公司 关于公司涉税事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、基本情况 罗牛山股份有限公司（以下简称"公司"）于2026年1月10日披露了《关于公司涉税事项的公告》（公告 编号：2026-002）。 二、进展情况及其他 1、就本次涉税事项，公司已与主管税务机关及国家税务总局海口市税务局（以下简称"海口市税务 局"）作了进一步汇报和沟通，详细说明了海南省农村信用社改革工作的政府统筹背景、整体进程及相 关实际情况，并补充提供了新的证据材料。经海口市税务局审查，认为公司提出的行政复议符合受理条 件，决定予以受理。2026年2月2日，公司收到海口市税务局出具的《受理行政复议申请通知书》（海税 复受字[2026]2号）。 2、公司将积极配合复议机关工作，依法陈述意见，维护自身合法权益。截至本公告发布之日，该事项 尚在审理过程中，最终结果尚不确定。 3、根据《企业会计准则第28号一一会计政策、会计估计变更和差错更正》 ...

证券代码：000735 证券简称：罗牛山 公告编号：2026-004 罗牛山股份有限公司 一、基本情况 罗牛山股份有限公司（以下简称"公司"）于 2026 年 1 月 10 日 披露了《关于公司涉税事项的公告》（公告编号：2026-002）。 二、进展情况及其他 1、就本次涉税事项，公司已与主管税务机关及国家税务总局海 口市税务局（以下简称"海口市税务局"）作了进一步汇报和沟通， 详细说明了海南省农村信用社改革工作的政府统筹背景、整体进程及 相关实际情况，并补充提供了新的证据材料。经海口市税务局审查， 认为公司提出的行政复议符合受理条件，决定予以受理。2026 年 2 月 2 日，公司收到海口市税务局出具的《受理行政复议申请通知书》 （海税复受字[2026]2 号）。 2、公司将积极配合复议机关工作，依法陈述意见，维护自身合 法权益。截至本公告发布之日，该事项尚在审理过程中，最终结果尚 不确定。 关于公司涉税事项的进展公告 3、根据《企业会计准则第 28 号——会计政策、会计估计变更和 差错更正》等相关规定，本次补缴税款及滞纳金事项不构成前期会计 差错，无需进行追溯调整，相关款项将计入公司 2025 年当期损 ...

证券日报网讯 2月2日，罗牛山（000735）在互动平台回答投资者提问时表示，截至2026年1月30日，公 司股东总户数约为12.81万户。 ...